Clinical Trials
71 trialsVG-INFUSE Tria
Fudan University
A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Janssen Research & Development, LLC
Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)
Mayo Clinic
En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer
Aarhus University Hospital
Comparison of Pathological Outcome and Recurrence Rate Between En Bloc and Conventional Transurethral Resection of Bladder Tumor
Lahore General Hospital
A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
UroGen Pharma Ltd.
PERTINENCE
Institut Cancerologie de l'Ouest
A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
Lipac Oncology LLC
Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER
AstraZeneca
Thulium Laser En-bloc Resection of Primary Non-muscle Invasive Bladder Cancer
Helwan University
The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer
A.O.U. Città della Salute e della Scienza
ADVANCED-1
Protara Therapeutics
ADVANCED-1
Protara Therapeutics
Comparison of BCG RIVM and Russian Strains for Treating Non-Muscle-Invasive Bladder Cancer (NMIBC)
Ankara University
CORE-001
CG Oncology, Inc.
BRAVE
University of Alberta
Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)
UroGen Pharma Ltd.
ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)
Ferring Pharmaceuticals
Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer
Wroclaw Medical University
START
University of Trieste
RESECT
British Urology Researchers in Surgical Training
Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer
Nucleix Ltd.
Evaluation of NanoDoce® in Participants With Urothelial Carcinoma
NanOlogy, LLC
VISTA
Sesen Bio, Inc.
RUTIVAC-1
Archivel Farma S.L.
Intravesical Electromotive Mitomycin After Bacillus Calmette-Guérin Failure
University of Rome Tor Vergata
BIC
Corewell Health West
VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer
Swiss Cancer Institute
A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer
Vaxiion Therapeutics
ANTICIPATE X
Cepheid
Antegrade Observational Comparative Study for the Intravesical Instillation Therapy of Bacillus Calmette Guerin With the Use of Different Types of Urinary Catheters in Patients With Urinary Bladder Cancer
National and Kapodistrian University of Athens
OPTIMA II
UroGen Pharma Ltd.
CANON
Viralytics
Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer
Halozyme Therapeutics
Evaluation of a Patient-Reported Symptom Index for NMIBC
University of Sydney
Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer
Aadi Bioscience, Inc.
Efficacy and Safety of Obturator Nerve Block During Transurethral Resection on Non-muscle Invasive Intermediate and High Risk Lateral Wall Bladder Tumours
Ankara Training and Research Hospital
Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer
Genomic Health®, Inc.
IMMUN VESSIE
University Hospital, Bordeaux
BUCEAH
Recep Tayyip Erdogan University Training and Research Hospital
Study of Continuous APL-1202 Treatment in Subjects With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Relapsed From Intravesical Chemo/BCG Therapy
Jiangsu Yahong Meditech Co., Ltd aka Asieris
NMIBC
AsierisPharma
Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study
Mansoura University
Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer
Anchiano Therapeutics Israel Ltd.
Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients
Theralase® Technologies Inc.
A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting
Photocure
NMIBCIVT
Mansoura University
Prospective Randomized Comparison of Transurethral Resection by Mean of White Light and Narrow Band Imaging
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection
University of Kansas Medical Center